Efficient in vitro expansion and gene modification are enabled, paving the way for "off-the-shelf" allogeneic therapy for hematologic malignancies and various solid tumors without requiring HLA matching.
Targeted Drug Delivery for CAR-NK Cell Therapy
Chimeric antigen receptor (CAR) natural killer (NK) cell therapy, a safe and universal next-generation immunotherapy, is limited by one technological bottleneck: the efficient and gentle delivery of CAR genes required for commercialization and efficacy breakthroughs. Creative Biolabs provides targeted delivery development, focusing on overcoming the inherent difficulty in transfecting NK cells, offering safe, efficient, and scalable engineered solutions.
What is Targeted Delivery (Gene Delivery) in CAR-NK?
Targeted delivery refers to the efficient, safe, and gentle introduction of CAR-encoding genetic material (typically mRNA or DNA) into Natural Killer (NK) cells in vitro. This initial process is fundamental, as NK cells are intrinsically resistant to external genetic modification. The key objective is to provide highly efficient non-viral carriers (like customized nanoparticles) or mild viral transduction solutions to address the inherent difficulty in transfecting NK cells. This initial gene delivery step dictates the final therapeutic product's yield, cost-effectiveness, and quality, paving the way for advanced functional engineering.
Applications for CAR-NK Cell Therapy
Targeted gene delivery enables a massive acceleration across the CAR-NK development lifecycle:
Universal Allogeneic CAR-NK Products
CAR-NK Function Enhancement
Successful delivery synergistically introduces genes for key functional molecules—such as IL-15, IL-21, or chemokine receptors (like CXCR4)—to enhance CAR-NK cell proliferation, improve in vivo survival, and boost tumor homing ability and persistence.
Novel CAR Structure Screening
Utilizing efficient mRNA delivery supports rapid, high-throughput, and multi-target CAR structure screening and optimization. This allows researchers to quickly identify and validate constructs with superior killing activity against heterogeneous tumor types, significantly streamlining R&D.
Fig.1 Nanoparticle-based delivery of CAR genes for the development of CAR-NK cell-based therapy.1
Delivery Challenges of CAR-NK Cell Therapy
Difficulty in Transfecting NK Cells Short In vivo Functional Duration CAR Expression and Functional Stability
NK cells are inherently sensitive to traditional transfection methods, including high-voltage electroporation and harsh viral vectors. They also exhibit poor cell membrane permeability, making it exceptionally difficult to achieve high-efficiency CAR gene delivery while maintaining cell viability.
What We Can Offer
We offer professional targeted gene delivery technologies, focusing on solving the efficiency, safety, and durability challenges inherent in CAR-NK therapy manufacturing:
Breakthrough NK Cell Transfection
We provide optimized LNP (Lipid Nanoparticle) and nanogel carriers, along with customized, mild transfection protocols tailored specifically to the physical and biological characteristics of NK cells. This methodology achieves high-viability and high-efficiency CAR gene (mRNA/DNA) delivery far surpassing industry standards.
Function-Enhancing Molecular Delivery
Our systems synergistically deliver persistence-enhancing genes like IL-15, IL-21, or anti-apoptotic molecules. This is critical for improving the in vitro expansion and in vivo durability of CAR-NK cells, directly addressing their challenge of a short survival rate post-infusion.
Allogeneic Product Manufacturing Optimization
Our non-viral delivery solutions offer high scalability, reduced immunogenicity, and low cost, perfectly supporting large-scale industrial CAR gene engineering workflows, particularly when utilizing iPSC-induced NK or cell line NK sources for universal therapies.
In vitro Functional Assessment Support
We provide detailed and robust assessment of the cytotoxicity, cytokine secretion profiles, and proliferation capacity of transfected CAR-NK cells. This quality control step ensures that vector modification and gene delivery does not negatively affect the cells' intrinsic natural killing activity or functional integrity.
Why Choose Us?
Deep NK Cell Expertise
Years specializing in NK cell biology and therapeutic engineering.
Proprietary Delivery Carriers
Exclusive access to custom LNP and nanogel platforms optimized for NK cell transfection efficiency.
Integrated Solutions
Our delivery expertise directly feeds into advanced functional engineering (homing, persistence, TME modulation).
Scalability
Proven, non-viral protocols designed for low-cost, high-volume, allogeneic manufacturing.
Workflow
Your universal CAR-NK therapy requires efficient, safe, and gentle delivery technology to succeed. Please contact our CAR-NK delivery expert team today for customized non-viral engineered solutions and to learn more about our advanced Targeted Delivery Strategies.
Reference
- Murugan, Dhanashree, et al. "Nanoparticle enhancement of Natural Killer (NK) cell-based immunotherapy." Cancers 14.21 (2022): 5438. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/cancers14215438.
Our services are For Research Use Only. We do not provide services to individuals.
Online Inquiry
